“Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer”, Arch Ital Urol Androl, vol. 88, no. 1, pp. 72–73, Mar. 2016, doi: 10.4081/aiua.2016.1.72.